Skip to main content
OpenTrials
Completed

NCT Number: NCT00840814

Developing a Checklist of Lymphedema Symptoms in Patients With Head and Neck Cancer

RATIONALE: Developing a symptom checklist for late-effect lymphedema may help doctors learn more about lymphedema in patients with head and neck cancer and plan the best treatment.

PURPOSE: This phase I/II trial is developing a checklist of lymphedema symptoms in patients with head and neck cancer.

Completed

Looking for future studies?

Notify Me

Key information

Age range

20 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States

Loading trial locations.

About this study

OBJECTIVES:

  • To develop and validate a symptom checklist for late-effect lymphedema in patients with head and neck cancer. (Phase I)
  • To examine late-effect lymphedema symptoms in these patients using the preliminary patient-symptom checklist developed in phase I. (Phase II)
  • To examine the psychometric properties of the patient symptom checklist. (Phase II)

OUTLINE:

  • Phase I: Experts review an initial symptom checklist for late-effect lymphedema symptoms and provide suggestions concerning its revision. The checklist is further revised using the card sorting method. Patients sort cards labeled with symptoms into groups that they feel are appropriate based upon their own symptom experiences. Sorting is performed according to frequency and severity of symptoms. Patients may write down any symptoms which are not listed on the cards.

Patients undergo collection of demographic and lymphedema-related symptom information. Additional medical information is obtained from patients' medical records.

  • Phase II: A final symptom checklist for late-effect lymphedema symptoms is constructed based on the preliminary checklist developed in phase I. The psychometric properties of the preliminary checklist are also assessed.

Patients undergo collection of demographic, lymphedema-related symptoms, and medical information as in phase I.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

DISEASE CHARACTERISTICS:

  • Meets 1 of the following criteria:
  • Patients meeting the following criteria:
  • Diagnosis of local squamous cell carcinoma of head and neck
  • Developed lymphedema after cancer treatment
  • No current evidence of cancer recurrence
  • No metastatic disease
  • Identified from oncology practices at the Vanderbilt-Ingram Cancer Center
  • Volunteer expert meeting the following criteria:
  • Member of the Pain and Symptom Management Team at Vanderbilt-Ingram Cancer Center OR faculty member/clinician associated with the Principal Investigator's prior clinical research at Vanderbilt Medical Center
  • Knowledgeable about the symptoms head and neck cancer patients experience

PATIENT CHARACTERISTICS:

  • No history of psychotic illness

PRIOR CONCURRENT THERAPY:

  • See Disease Characteristics
  • More than 3 months since prior cancer treatment
  • No concurrent chemotherapy or radiotherapy
  • No concurrent anti-psychotic medication

Treatment and study plan

Primary outcomes

  1. Late-effect lymphedema symptom checklist

    Time frame: cross-sectional study

  2. Psychometric properties of the patient symptom checklist (Phase II)

    Time frame: cross-sectional study

Sponsors and collaborators

Lead sponsor

Vanderbilt University

Other

Collaborators

  • National Cancer Institute (NCI)

Registry information

Official study title

Development of a Lymphedema Symptom Checklist in Head and Neck Cancer Patients

Important dates

Study start
2008
Primary completion
2012
Study completion
2012
First posted
Feb 10, 2009
Registry last updated
Apr 7, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.